Skip to main content
PortfolioPoseida Therapeutics, Inc.

Poseida Awarded $3.99 Million CIRM Grant to Support Preclinical Development of P-PSMA-101, a T Stem Cell Memory CAR-T Therapy for Prostate Cancer

By July 20, 2018March 15th, 2021No Comments